Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO, Jan. 14, 2008 (PRIME NEWSWIRE) -- Cannasat Therapeutics ("Cannasat" or the "Company") (TSX-V:CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced that Dr....
-
TORONTO, Dec. 4, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH), a company specializing in the development of cannabinoid-based pharmaceutical products, announced today...
-
TORONTO, Nov. 8, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics (TSX-V:CTH) (the "Company") today announced that it has retained The Equicom Group ("Equicom") to provide the Company with strategic...
-
TORONTO, Oct. 30, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics (TSX-V:CTH) (the "Company"), the developer of novel cannabinoid-based pharmaceutical products, today announced that George Nomikos,...
-
TORONTO, Sept. 17, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH), a company specializing in the development of cannabinoid-based pharmaceutical products, announced today...
-
TORONTO, Aug. 28, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. (TSX-V:CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the six months...
-
TORONTO, Aug. 23, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH) announced today that Health Canada has approved Cannasat's clinical trial application for a Phase 1...